Vancomycin in CRRT with oXiris filter study
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the antibiotic vancomycin behaves in the blood of patients who are on a special type of kidney support (CRRT) using the oXiris filter. It aims to help doctors dose vancomycin more accurately for patients in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You are in the intensive care unit at Ramathibodi Hospital
- You are on a blood filtering treatment called CRRT using the oXiris filter
- You have received at least one dose of the antibiotic vancomycin after starting this filtering treatment
- You do not have a history of allergy to vancomycin
- You are not on ECMO, do not have a kidney transplant, are not pregnant or breastfeeding, and are not on dialysis or palliative care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests a special blood filter (Oxiris) in patients with sepsis who also have acute kidney injury. The filter may help clean the blood better and support kidney recovery.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
Hear when a new AKI - Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.